ABBV - AbbVie Inc. Latest News | Finranks

27.03.2026

AbbVie: Strong 2026 Outlook, Expect Dividend Increases

AbbVie remains well-positioned for long-term growth, despite recent share price consolidation and near-term geopolitical headwinds. I expect Skyrizi and Rinvoq to drive double-digit revenue growth in 2026 and ahead of the company's initial guidance. With Humira erosion largely in the rearview mirror, I anticipate accelerating dividend increases and increased business development activity as the previous acquisitions are digested.

27.03.2026

AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting

Data highlights efficacy and safety of risankizumab in psoriatic disease, including high impact areas in psoriasis and long-term treatment of psoriatic arthritis Data includes real-world evidence of minimal disease activity and clinical long-term safety outcomes of upadacitinib in atopic dermatitis, as well as investigational Phase 3 data for vitiligo and alopecia areata NORTH CHICAGO, Ill., March 27, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new research across its dermatology portfolio to be presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting, March 27–31 in Denver, Colorado.

27.03.2026

Here's How Many Shares of AbbVie (ABBV) Stock You'd Need for $10,000 in Yearly Dividends

AbbVie has increased its dividend by more than 330% since 2013. It has a robust pipeline of drugs in development and growing revenue, too.

25.03.2026

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.

25.03.2026

LLY or ABBV: Which Drugmaker is Likely to Offer Better Upside in 2026?

LLY's obesity drugs fuel explosive growth, while ABBV depends on Skyrizi and Rinvoq. Let's see which drugmaker has the stronger 2026 outlook.

24.03.2026

AbbVie Named Official Pharmaceutical Partner of Major League Baseball

Partnership expands "Striking Out Cancer" campaign beginning on Opening Day AbbVie named Official Pharmaceutical Partner of Major League Baseball (MLB), expanding Striking Out Cancer league-wide starting on Opening Day Each strikeout will trigger a donation from AbbVie to support Stand Up To Cancer Integrated across every game and key MLB events, Striking Out Cancer transforms baseball's most iconic moments into season-long national impact NORTH CHICAGO, Ill., March 24, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced a multi-year partnership with Major League Baseball (MLB), naming AbbVie the Official Pharmaceutical Partner of MLB beginning with the 2026 season.

24.03.2026

What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill.

Both companies have distributions boasting above-average yields. One is even a Dividend King.

Videos

13.01.2026

Positive

AbbVie reaches 3-year deal with White House to lower drug prices

17.12.2025

Neutral

Final Trades: Abbvie Inc, Microsoft, Netflix and Twilio Inc

Upgrades / Downgrades

Ticker	Brokerage Firm	Ratings Change	Price Target	Date
ABBV	Citigroup	Neutral	undefined >> $205	May 14th 2025
ABBV	Cantor Fitzgerald	Overweight	undefined >> $210	April 22nd 2025
ABBV	Daiwa Securities	Neutral	undefined >> $180	December 5th 2024
ABBV	Leerink Partners	Outperform	undefined >> $206	November 22nd 2024
ABBV	Wolfe Research	Outperform	undefined >> $205	November 15th 2024
ABBV	Argus	Buy	undefined >> undefined	November 4th 2024
ABBV	Bernstein	Market Perform	undefined >> $203	October 17th 2024
ABBV	HSBC Securities	Buy	undefined >> $185	June 5th 2024

Press releases

27.03.2026

AbbVie Inc. (ABBV)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

AbbVie Inc. (ABBV)

AbbVie: Strong 2026 Outlook, Expect Dividend Increases

AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting

Here's How Many Shares of AbbVie (ABBV) Stock You'd Need for $10,000 in Yearly Dividends

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

LLY or ABBV: Which Drugmaker is Likely to Offer Better Upside in 2026?

AbbVie Named Official Pharmaceutical Partner of Major League Baseball

What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill.

Videos

Upgrades / Downgrades

Press releases

AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting

AbbVie Named Official Pharmaceutical Partner of Major League Baseball

Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions

New York Plastic Surgical Group and Deep Blue Med Spa Named #1 in New York by Allergan Aesthetics for the Second Year in a Row